Cargando…
Approach to persistent ascites after liver transplantation
Persistent ascites (PA) after liver transplantation (LT), commonly defined as ascites lasting more than 4 wk after LT, can be expected in up to 7% of patients. Despite being relatively rare, it is associated with worse clinical outcomes, including higher 1-year mortality. The cause of PA can be divi...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521448/ https://www.ncbi.nlm.nih.gov/pubmed/36185723 http://dx.doi.org/10.4254/wjh.v14.i9.1739 |
_version_ | 1784799840048250880 |
---|---|
author | Ostojic, Ana Petrovic, Igor Silovski, Hrvoje Kosuta, Iva Sremac, Maja Mrzljak, Anna |
author_facet | Ostojic, Ana Petrovic, Igor Silovski, Hrvoje Kosuta, Iva Sremac, Maja Mrzljak, Anna |
author_sort | Ostojic, Ana |
collection | PubMed |
description | Persistent ascites (PA) after liver transplantation (LT), commonly defined as ascites lasting more than 4 wk after LT, can be expected in up to 7% of patients. Despite being relatively rare, it is associated with worse clinical outcomes, including higher 1-year mortality. The cause of PA can be divided into vascular, hepatic, or extrahepatic. Vascular causes of PA include hepatic outflow and inflow obstructions, which are usually successfully treated. Regarding modifiable hepatic causes, recurrent hepatitis C and acute cellular rejection are the leading ones. Considering predictors for PA, the presence of ascites, refractory ascites, hepato-renal syndrome type 1, spontaneous bacterial peritonitis, hepatic encephalopathy, and prolonged ischemic time significantly influence the development of PA after LT. The initial approach to patients with PA should be to diagnose the treatable cause of PA. The stepwise approach in evaluating PA includes diagnostic paracentesis, ultrasound with Doppler, and an echocardiogram when a cardiac cause is suspected. Finally, a percutaneous or transjugular liver biopsy should be performed in cases where the diagnosis is unclear. PA of unknown cause should be treated with diuretics and paracentesis, while transjugular intrahepatic portosystemic shunt and splenic artery embolization are treatment methods in patients with refractory ascites after LT. |
format | Online Article Text |
id | pubmed-9521448 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-95214482022-09-30 Approach to persistent ascites after liver transplantation Ostojic, Ana Petrovic, Igor Silovski, Hrvoje Kosuta, Iva Sremac, Maja Mrzljak, Anna World J Hepatol Minireviews Persistent ascites (PA) after liver transplantation (LT), commonly defined as ascites lasting more than 4 wk after LT, can be expected in up to 7% of patients. Despite being relatively rare, it is associated with worse clinical outcomes, including higher 1-year mortality. The cause of PA can be divided into vascular, hepatic, or extrahepatic. Vascular causes of PA include hepatic outflow and inflow obstructions, which are usually successfully treated. Regarding modifiable hepatic causes, recurrent hepatitis C and acute cellular rejection are the leading ones. Considering predictors for PA, the presence of ascites, refractory ascites, hepato-renal syndrome type 1, spontaneous bacterial peritonitis, hepatic encephalopathy, and prolonged ischemic time significantly influence the development of PA after LT. The initial approach to patients with PA should be to diagnose the treatable cause of PA. The stepwise approach in evaluating PA includes diagnostic paracentesis, ultrasound with Doppler, and an echocardiogram when a cardiac cause is suspected. Finally, a percutaneous or transjugular liver biopsy should be performed in cases where the diagnosis is unclear. PA of unknown cause should be treated with diuretics and paracentesis, while transjugular intrahepatic portosystemic shunt and splenic artery embolization are treatment methods in patients with refractory ascites after LT. Baishideng Publishing Group Inc 2022-09-27 2022-09-27 /pmc/articles/PMC9521448/ /pubmed/36185723 http://dx.doi.org/10.4254/wjh.v14.i9.1739 Text en ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. |
spellingShingle | Minireviews Ostojic, Ana Petrovic, Igor Silovski, Hrvoje Kosuta, Iva Sremac, Maja Mrzljak, Anna Approach to persistent ascites after liver transplantation |
title | Approach to persistent ascites after liver transplantation |
title_full | Approach to persistent ascites after liver transplantation |
title_fullStr | Approach to persistent ascites after liver transplantation |
title_full_unstemmed | Approach to persistent ascites after liver transplantation |
title_short | Approach to persistent ascites after liver transplantation |
title_sort | approach to persistent ascites after liver transplantation |
topic | Minireviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521448/ https://www.ncbi.nlm.nih.gov/pubmed/36185723 http://dx.doi.org/10.4254/wjh.v14.i9.1739 |
work_keys_str_mv | AT ostojicana approachtopersistentascitesafterlivertransplantation AT petrovicigor approachtopersistentascitesafterlivertransplantation AT silovskihrvoje approachtopersistentascitesafterlivertransplantation AT kosutaiva approachtopersistentascitesafterlivertransplantation AT sremacmaja approachtopersistentascitesafterlivertransplantation AT mrzljakanna approachtopersistentascitesafterlivertransplantation |